Attentiveness of pediatricians to primary immunodeficiency disorders

Suleiman Al-Hammadi1, Eiman Al-Reyami, Sareea Al-Remeithi

  • 1Department of Pediatrics, UAE University, Al-Ain, United Arab Emirates. suleiman.alhammadi@uaeu.ac.ae

BMC Research Notes
|August 1, 2012
PubMed

Insights

Pediatricians in the UAE showed significant gaps in diagnosing primary immunodeficiency (PID) disorders, highlighting a need for improved educational strategies. This study assessed PID knowledge among 263 pediatricians, revealing deficiencies in work-up and management.

Area of Science:

  • Pediatric immunology
  • Clinical diagnostics
  • Medical education

Background:

  • Primary immunodeficiency (PID) comprises serious disorders requiring vigilant diagnosis and management.
  • This study investigated PID knowledge and experience among diverse pediatricians in the United Arab Emirates (UAE).

Purpose of the Study:

  • To assess the competency of pediatricians in the UAE regarding PID knowledge and practical application.
  • To identify specific areas of deficiency in PID diagnosis and management among pediatricians.

Main Methods:

  • A self-administered questionnaire assessed knowledge of PID signs, symptoms, syndromes, screening, and management.
  • The study included 263 pediatricians from 27 governmental hospitals across all regions of the UAE.

Main Results:

  • Pediatrician performance was not influenced by age, gender, certification, rank, or experience.
  • 76% of pediatricians scored 60-79% on PID knowledge questions; only 4% scored ≥80%.
  • While PID signs, symptoms, and screening tests were recognized, interpretation of age-specific laboratory reference ranges was limited.

Conclusions:

  • A notable deficiency exists in the work-up of primary immunodeficiency disorders among UAE pediatricians.
  • Effective educational strategies are essential to enhance pediatrician competency in diagnosing and managing PID.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...